C G Roehrborn

发表

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.

P. Boyle, C. Roehrborn, R. deVere White, 1999, Urology.

Interexaminer reliability of transrectal ultrasound for estimating prostate volume.

C. Roehrborn, C. Girman, C G Roehrborn, 2001, The Journal of urology.

Use of a prostate model to assist in training for digital rectal examination.

C. Roehrborn, C. Girman, C G Roehrborn, 2000, Urology.

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

L K Lloyd, J. Oesterling, C. Roehrborn, 1996, Urology.

Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.

C. Roehrborn, G. J. Pickens, C G Roehrborn, 1996, Urology.

Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination.

C. Roehrborn, C. Girman, C G Roehrborn, 2001, Urology.

Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens.

C G Roehrborn, B Djavan, M Marberger, 1998, European urology.

Benign prostatic hyperplasia.

C. Roehrborn, M. Barry, M J Barry, 2020, BMJ.

Gleason score predicts androgen independent progression after androgen deprivation therapy.

C. Roehrborn, C G Roehrborn, E A Benaim, 2002, European urology.

The impact of intense laparoscopic skills training on the operative performance of urology residents.

D. Scott, C. Roehrborn, J. A. Cadeddu, 2001, The Journal of urology.

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound.

G N Collins, C. Roehrborn, W. Garraway, 1997, Urology.

Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

C. Roehrborn, C G Roehrborn, R L Siegel, 1996, Urology.

Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data

M. Stokes, C. Roehrborn, Á. Benedict, 2010, Prostate Cancer and Prostatic Diseases.

Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?

C G Roehrborn, J D McConnell, M C Hall, 1996, Seminars in urologic oncology.

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials.

A L Gould, P. Boyle, C. Roehrborn, 1996, Urology.